Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 8751-8800 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05310981
A Cannabis E-intervention for Young Cannabis Users With Early Psychosis (iCC)
NA
Active, not recruiting
100 participants
Started: Jul 6, 2022 · Completed: Jul 31, 2024
1 condition
2 sponsors
5 locations
NCT05423262
A Study of TRK-950 in Patients With Advanced Solid Tumors
PHASE1/PHASE2
Active, not recruiting
49 participants
Started: Jul 6, 2022 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT05363267
NF-1, Nutraceutical Intervention
PHASE1
Active, not recruiting
23 participants
Started: Jul 6, 2022 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT04576091
Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer
PHASE1
Active, not recruiting
7 participants
Started: Jul 6, 2022 · Completed: Dec 11, 2025
32 conditions
1 sponsor
11 locations
NCT05315661
The Safety and The Efficacy Evaluation of ET-STEM in Patients With Frontotemporal Dementia
PHASE1
Active, not recruiting
12 participants
Started: Jul 6, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05252429
Docetaxel/Pembrolizumab in Head and Neck Squamous Cell Carcinoma
PHASE2
Active, not recruiting
27 participants
Started: Jul 6, 2022 · Completed: Nov 30, 2025
1 condition
2 sponsors
1 location
NCT04324944
Adapting and Examining Collaborative Decision Skills Training Among Veterans With Serious Mental Illness
NA
Active, not recruiting
39 participants
Started: Jul 5, 2022 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT06053697
Is the Vaginal Microbiome and Metabolome Associated With Spontaneous Preterm Birth (sPTB) in Multiple Pregnancies?
N/A
Active, not recruiting
120 participants
Started: Jul 5, 2022 · Completed: Apr 30, 2026
8 conditions
3 sponsors
1 location
NCT05393648
Bipolar Efficacy Biomarkers for rTMS
NA
Active, not recruiting
60 participants
Started: Jul 5, 2022 · Completed: Dec 31, 2025
2 conditions
3 sponsors
1 location
NCT05096260
Getting to Yes, Michigan! (G2YMI)
NA
Active, not recruiting
700 participants
Started: Jul 5, 2022 · Completed: Mar 11, 2026
2 conditions
3 sponsors
1 location
NCT05128903
Quantitative Assessment of Radiation-induced Neuroinflammation - A Proof of Principle Study
PHASE2
Active, not recruiting
22 participants
Started: Jul 5, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT06546332
Post Market Clinical Follow-Up KeriFuse®
N/A
Active, not recruiting
97 participants
Started: Jul 5, 2022 · Completed: Mar 31, 2027
1 condition
1 sponsor
6 locations
NCT05135611
The Efficacy of the 4-channel Sequential NMES for the Treatment of Sleep Apnea
NA
Active, not recruiting
11 participants
Started: Jul 5, 2022 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT05389267
Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients.
PHASE1/PHASE2
Active, not recruiting
120 participants
Started: Jul 5, 2022 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT05415215
A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer
PHASE3
Active, not recruiting
347 participants
Started: Jul 5, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
45 locations
NCT05379634
A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
PHASE2
Active, not recruiting
36 participants
Started: Jul 5, 2022 · Completed: Sep 16, 2026
1 condition
1 sponsor
57 locations
NCT07164235
Spondylodiscitis: a Retrospective Observational Study.
N/A
Active, not recruiting
137 participants
Started: Jul 5, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05400980
Expander-2 Trial: Randomized Study to Evaluate Safety & Efficacy of the Urocross® Expander System & Retrieval Sheath
NA
Active, not recruiting
240 participants
Started: Jul 5, 2022 · Completed: Dec 31, 2028
1 condition
1 sponsor
2 locations
NCT05176444
Managing the Needs of Care Home Residents With Dementia Through a Music Therapy Intervention
NA
Active, not recruiting
84 participants
Started: Jul 4, 2022 · Completed: Jun 30, 2024
2 conditions
3 sponsors
11 locations
NCT05393193
POC HIV Testing and Early DTG Use for Infants
PHASE4
Active, not recruiting
900 participants
Started: Jul 4, 2022 · Completed: Aug 31, 2026
1 condition
5 sponsors
1 location
NCT06095375
Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients
PHASE1
Active, not recruiting
36 participants
Started: Jul 4, 2022 · Completed: Dec 31, 2025
2 conditions
2 sponsors
2 locations
NCT05466292
Evaluating a Clinical Ethics Committee (CEC) Implementation Process
N/A
Active, not recruiting
20 participants
Started: Jul 4, 2022 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05415072
A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas
PHASE1/PHASE2
Active, not recruiting
66 participants
Started: Jul 4, 2022 · Completed: Oct 1, 2027
1 condition
1 sponsor
11 locations
NCT05442840
Evaluation of Pharmacist Intervention for Individuals With Uncontrolled Type 2 Diabetes
NA
Active, not recruiting
60 participants
Started: Jul 4, 2022 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT05468268
Noninvasive Brain Stimulation for pAD
NA
Active, not recruiting
40 participants
Started: Jul 4, 2022 · Completed: Dec 4, 2025
1 condition
4 sponsors
1 location
NCT05256979
Ursodeoxycholic Acid in Patients With NAFLD - Clinical Observation
N/A
Active, not recruiting
20 participants
Started: Jul 2, 2022 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT06196827
Safety and Tolerability of LX101 for Inherited Retinal Dystrophy Associated With RPE65 Mutations
PHASE1/PHASE2
Active, not recruiting
9 participants
Started: Jul 2, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
2 locations
NCT05432375
Study of Tinostamustine for Adjuvant Treatment of Glioblastoma
EARLY_PHASE1
Active, not recruiting
12 participants
Started: Jul 1, 2022 · Completed: Nov 30, 2024
1 condition
1 sponsor
5 locations
NCT05409651
Phenotyping Mitochondrial and Immune Dysfunction in POTS With Targeted Clinical Intervention.
NA
Active, not recruiting
25 participants
Started: Jul 1, 2022 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
NCT05276063
A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
PHASE2/PHASE3
Active, not recruiting
90 participants
Started: Jul 1, 2022 · Completed: Sep 30, 2026
12 conditions
1 sponsor
30 locations
NCT05648227
Validation of an Artificial Intelligence Enabled Diagnostic Support Software (ArtiQ.Spiro) in Primary Care Spirometry Datasets - a Retrospective Analysis
N/A
Active, not recruiting
1,000 participants
Started: Jul 1, 2022 · Completed: Feb 28, 2025
1 condition
9 sponsors
1 location
NCT05297396
Slow Opioid Tapering Pilot Study of Patients Using Chronic Opioid Therapy
NA
Active, not recruiting
22 participants
Started: Jul 1, 2022 · Completed: Dec 1, 2025
2 conditions
1 sponsor
2 locations
NCT05972785
Long-term Use of CCB and Breast Cancer Risk
N/A
Active, not recruiting
68,500 participants
Started: Jul 1, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05099705
Testing a Family Service Navigator Program for Low-resourced Families of Young Children with Autism Spectrum Disorder
NA
Active, not recruiting
55 participants
Started: Jul 1, 2022 · Completed: Apr 30, 2026
2 conditions
1 sponsor
1 location
NCT05918133
A Study of PM8002 Plus Nab-paclitaxel as First Line Therapy for TNBC
PHASE1/PHASE2
Active, not recruiting
42 participants
Started: Jul 1, 2022 · Completed: Oct 30, 2026
1 condition
1 sponsor
8 locations
NCT05336266
A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarcinoma
EARLY_PHASE1
Active, not recruiting
28 participants
Started: Jul 1, 2022 · Completed: Dec 5, 2026
3 conditions
2 sponsors
1 location
NCT06102291
Acupoint Application With Yanqing Zhitong Ointment for Chronic Non-specific Low Back Pain
NA
Active, not recruiting
150 participants
Started: Jul 1, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05610748
Implant-supported Rehabilitation With SPAL Technique or Soft Tissue Augmentation
PHASE4
Active, not recruiting
66 participants
Started: Jul 1, 2022 · Completed: Dec 31, 2025
3 conditions
2 sponsors
1 location
NCT05170438
Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment
PHASE2
Active, not recruiting
51 participants
Started: Jul 1, 2022 · Completed: Jun 30, 2028
1 condition
8 sponsors
8 locations
NCT04827862
RADVAX™ for Relapsed/Refractory Non-Hodgkin Lymphoma: A Phase II Trial of Pembrolizumab + Low Dose Radiotherapy
PHASE2
Active, not recruiting
6 participants
Started: Jul 1, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05275725
Finding Solutions to Thrive After Birth Asphyxia in Africa
PHASE1
Active, not recruiting
18 participants
Started: Jul 1, 2022 · Completed: Jan 31, 2025
1 condition
4 sponsors
1 location
NCT05258279
Lenvatinib in Combination With Carboplatin Pemetrexed and Pembrolizumab for NSCLC With EGFR Mutations
PHASE2
Active, not recruiting
30 participants
Started: Jul 1, 2022 · Completed: Oct 31, 2024
2 conditions
2 sponsors
10 locations
NCT05931003
Reconstruction of the Carotid Bifurcation in Patients With Arterial Hypertension of 2-3 Degrees
NA
Active, not recruiting
90 participants
Started: Jul 1, 2022 · Completed: Sep 1, 2026
3 conditions
1 sponsor
1 location
NCT04978727
A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma
PHASE1
Active, not recruiting
35 participants
Started: Jul 1, 2022 · Completed: Feb 28, 2030
8 conditions
4 sponsors
14 locations
NCT05120284
Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)
PHASE2
Active, not recruiting
40 participants
Started: Jul 1, 2022 · Completed: Aug 31, 2026
1 condition
1 sponsor
2 locations
NCT05176470
Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients
PHASE1
Active, not recruiting
2 participants
Started: Jul 1, 2022 · Completed: Dec 31, 2025
5 conditions
2 sponsors
1 location
NCT05430659
Intraoperative Estimated Blood Loss, Blood Transfusion, and Postoperative Clinical Outcomes in Patients Undergoing Non Cardiac Surgery, Siriraj Hospital
N/A
Active, not recruiting
1,268 participants
Started: Jul 1, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT06312384
The Influence of 3D Surgical Template on the Contour of Bone Augmentation, in Patient With Labial Alveolar Ridge Defect and Simultaneous Implantation
PHASE3
Active, not recruiting
20 participants
Started: Jul 1, 2022 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT05652400
HIV Transmission in the Era of Scaling up Antiretroviral Therapy in Ethiopia
N/A
Active, not recruiting
2,400 participants
Started: Jul 1, 2022 · Completed: Jan 31, 2026
2 conditions
4 sponsors
1 location
NCT06458322
Quality of Life in Patients Transitioning to Home or In-Center Dialysis (QUALIFY CKD-to-HOME)
N/A
Active, not recruiting
200 participants
Started: Jul 1, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
Previous
1
More pages
173
174
175
176
177
178
179
More pages
431
Next